Izotropic (OTCMKTS:IZOZF – Get Rating) and ICON Public (NASDAQ:ICLR – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.
Insider & Institutional Ownership
89.9% of ICON Public shares are held by institutional investors. 44.0% of ICON Public shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a summary of recent ratings and price targets for Izotropic and ICON Public, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Izotropic | 0 | 0 | 0 | 0 | N/A |
| ICON Public | 0 | 1 | 9 | 0 | 2.90 |
Earnings & Valuation
This table compares Izotropic and ICON Public’s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Izotropic | N/A | N/A | N/A | N/A | N/A |
| ICON Public | $7.82 billion | 2.41 | $505.30 million | $6.18 | 37.26 |
ICON Public has higher revenue and earnings than Izotropic.
Profitability
This table compares Izotropic and ICON Public’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Izotropic | N/A | N/A | N/A |
| ICON Public | 6.52% | 11.16% | 5.45% |
Summary
ICON Public beats Izotropic on 8 of the 8 factors compared between the two stocks.
About Izotropic
Izotropic Corporation, a MedTech company, commercializes diagnostic products for breast cancer. It develops and commercializes breast CT Imaging system; and 3D CT breast imaging platform for the earlier detection and diagnosis of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
About ICON Public
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; and clinical research services, including biostatistics, clinical operations, clinical supplies management, covid-19, data management, decentralized & hybrid clinical solutions, endpoint adjudication services, interactive response technologies, investigator payments, medical affairs, medical writing and publishing, pharmacovigilance, and site and patient solutions. The company also provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. In addition, it offers commercial positioning, early phase, language, medical imaging, and strategic solutions, as well as clinical trial management, consulting, and contract staffing services. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
